Related references
Note: Only part of the references are listed.Nicotine Increases Spontaneous Glutamate Release in the Rostromedial Tegmental Nucleus
Diego Castillo-Rolon et al.
FRONTIERS IN NEUROSCIENCE (2021)
The associations of smoking dependence motives with depression among daily smokers
Maarit Piirtola et al.
ADDICTION (2021)
Different Classes of Antidepressants Inhibit the Rat α7 Nicotinic Acetylcholine Receptor by Interacting within the Ion Channel: A Functional and Structural Study
Yorley Duarte et al.
MOLECULES (2021)
Use of alcohol, drugs, inhalants, and smoking tobacco and the long-term risk of depression in men: A nationwide Swedish cohort study from 1969-2017
Ambra Gentile et al.
DRUG AND ALCOHOL DEPENDENCE (2021)
Nicotine smoking concentrations modulate GABAergic synaptic transmission in murine medial prefrontal cortex by activation of α7*and β2*nicotinic receptors
Roberto Cuevas-Olguin et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2020)
A Single Administration of the Atypical Psychedelic Ibogaine or Its Metabolite Noribogaine Induces an Antidepressant-Like Effect in Rats
Paola Rodriguez et al.
ACS CHEMICAL NEUROSCIENCE (2020)
The rostromedial tegmental nucleus modulates the development of stress-induced helpless behavior
G. I. Elmer et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics
Stephanie C. Dulawa et al.
MOLECULAR PSYCHIATRY (2019)
被撤回的出版物: Chronic fluoxetine treatment in vivo enhances excitatory synaptic transmission in the hippocampus (Retracted article. See vol. 216, 2022)
Adam M. Van Dyke et al.
NEUROPHARMACOLOGY (2019)
Selectivity of ( ± )-citalopram at nicotinic acetylcholine receptors and different inhibitory mechanisms between habenular α3β4*and α9α10 subtypes
Hugo R. Arias et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
Reference Brain/Blood Concentrations of Citalopram, Duloxetine, Mirtazapine and Sertraline
Michael Nedahl et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2018)
Tricyclic antidepressants inhibit hippocampal α7*and α9α10 nicotinic acetylcholine receptors by different mechanisms
Hugo R. Arias et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula
Hugo R. Arias et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
Dopamine System Dysregulation in Major Depressive Disorders
Pauline Belujon et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
X-ray structure of the human α4β2 nicotinic receptor
Claudio L. Morales-Perez et al.
NATURE (2016)
Anti-inflammatory, antiapoptotic, and antioxidant activity of fluoxetine
Vitor Caiaffo et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2016)
Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites
Hugo R. Arias et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Synthesis and Evaluation of Novel 2,3-Dihydrobenzo[b][1,4]dioxin- and Indolealkylamine Derivatives as Potential Antidepressants
Songlin Wang et al.
ARCHIV DER PHARMAZIE (2014)
FLUOXETINE PREVENTS ACETYLCHOLINE-INDUCED EXCITOTOXICITY BLOCKING HUMAN ENDPLATE ACETYLCHOLINE RECEPTOR
Cristina Deflorio et al.
MUSCLE & NERVE (2014)
Molecules and circuits involved in nicotine addiction: The many faces of smoking
Marina R. Picciotto et al.
NEUROPHARMACOLOGY (2014)
Efficacy of Sequential Use of Fluoxetine for Smoking Cessation in Elevated Depressive Symptom Smokers
Richard A. Brown et al.
NICOTINE & TOBACCO RESEARCH (2014)
A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy
Jeremy D. Coplan et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2014)
Antidepressants for smoking cessation
John R. Hughes et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
The potent and selective α4β2*/α6*-nicotinic acetylcholine receptor partial agonist 2-[5-[5-((S)Azetidin-2-ylmethoxy) -3-pyridinyl]-3-isoxazolyl]ethanol demonstrates antidepressive-like behavior in animal models and a favorable ADME-tox profile
Li-Fang Yu et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2014)
Cognition as a therapeutic target in late-life depression: Potential for nicotinic therapeutics
Lilia Zurkovsky et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Complex relationships of nicotinic receptor actions and cognitive functions
Edward D. Levin
BIOCHEMICAL PHARMACOLOGY (2013)
Changes in the Cholinergic System between Bipolar Depression and Euthymia as Measured with [123I]5IA Single Photon Emission Computed Tomography
Jonas O. Hannestad et al.
BIOLOGICAL PSYCHIATRY (2013)
Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release
Kazuki Nagayasu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
(-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites
Hugo R. Arias et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Therapeutic doses of antidepressants are projected not to inhibit human α4β2 nicotinic acetylcholine receptors
Mark L. Weber et al.
NEUROPHARMACOLOGY (2013)
Cholinergic receptors: functional role of nicotinic ACh receptors in brain circuits and disease
Jerrel L. Yakel
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2013)
Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior
Yann S. Mineur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A gating mechanism of pentameric ligand-gated ion channels
Nicolas Calimet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Selective Serotonin Reuptake Inhibitor Exposure
Kevin T. Fitzgerald et al.
TOPICS IN COMPANION ANIMAL MEDICINE (2013)
Functional and Structural Interaction of (-)-Reboxetine with the Human α4β2 Nicotinic Acetylcholine Receptor
Hugo R. Arias et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Persistent β2*-Nicotinic Acetylcholinergic Receptor Dysfunction in Major Depressive Disorder
Aybala Saricicek et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Genetics of smoking and depression
Ming T. Tsuang et al.
HUMAN GENETICS (2012)
The Nicotinic Acetylcholine Receptor: The Founding Father of the Pentameric Ligand-gated Ion Channel Superfamily
Jean-Pierre Changeux
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome
Amina Chaouch et al.
JOURNAL OF NEUROLOGY (2012)
Fluoxetine (Prozac) and Serotonin Act on Excitatory Synaptic Transmission to Suppress Single Layer 2/3 Pyramidal Neuron-Triggered Cell Assemblies in the Human Prefrontal Cortex
Gergely Komlosi et al.
JOURNAL OF NEUROSCIENCE (2012)
Direct Alteration of a Specific Inhibitory Circuit of the Hippocampus by Antidepressants
Pablo Mendez et al.
JOURNAL OF NEUROSCIENCE (2012)
Presynaptic α4β2 Nicotinic Acetylcholine Receptors Increase Glutamate Release and Serotonin Neuron Excitability in the Dorsal Raphe Nucleus
Julieta Garduno et al.
JOURNAL OF NEUROSCIENCE (2012)
Regulation of hippocampal inhibitory circuits by nicotinic acetylcholine receptors
Marilena Griguoli et al.
JOURNAL OF PHYSIOLOGY-LONDON (2012)
Structural and functional interaction of (±)-2-(N-tert-butylamino)-3′-iodo-4′-azidopropiophenone, a photoreactive bupropion derivative, with nicotinic acetylcholine receptors
Hugo R. Arias et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Bimodal effects of fluoxetine on cerebral nitrergic neurogenic vasodilation in porcine large cerebral arteries
Mei-Fang Chen et al.
NEUROPHARMACOLOGY (2012)
Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: A comparison of SSR180711 and PNU-282987
Jesper T. Andreasen et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
The prefrontal cortex influence over subcortical and limbic regions governs antidepressant response by N=H/(M+R)
Alen Johannes Salerian et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2012)
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Ronald S. Duman et al.
SCIENCE (2012)
Where in the Brain Is Depression?
Mayur Pandya et al.
CURRENT PSYCHIATRY REPORTS (2012)
Inhibitory control of hippocampal inhibitory neurons
Simon Chamberland et al.
FRONTIERS IN NEUROSCIENCE (2012)
Nicotinic excitation of serotonergic projections from dorsal raphe to the nucleus accumbens
Ben Chang et al.
JOURNAL OF NEUROPHYSIOLOGY (2011)
Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test
Jesper T. Andreasen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline
Jesper T. Andreasen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Examining antidepressant drug response by smoking status: why is it important and how often is it done?
Andrea H. Weinberger et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
The GABAergic deficit hypothesis of major depressive disorder
B. Luscher et al.
MOLECULAR PSYCHIATRY (2011)
Arginine residues at internal positions in a protein are always charged
Michael J. Harms et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes
Antonio Drago et al.
PROGRESS IN NEUROBIOLOGY (2011)
Interaction of Selective Serotonin Reuptake Inhibitors with Neuronal Nicotinic Acetylcholine Receptors
Hugo R. Arias et al.
BIOCHEMISTRY (2010)
Tricyclic antidepressants and mecamylamine bind to different sites in the human α4β2 nicotinic receptor ion channel
Hugo R. Arias et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Inhibitory mechanisms and binding site location for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptors
Hugo R. Arias et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Different interaction between tricyclic antidepressants and mecamylamine with the human α3β4 nicotinic acetylcholine receptor ion channel
Hugo R. Arias et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Tobacco addiction: A biochemical model of nicotine dependence
Marcelo O. Ortells et al.
MEDICAL HYPOTHESES (2010)
Presynaptic nicotinic receptors modulating neurotransmitter release in the Central Nervous System: Functional interactions with other coexisting receptors
Mario Marchi et al.
PROGRESS IN NEUROBIOLOGY (2010)
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
Yann S. Mineur et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Reduced α4β2*-Nicotinic Acetylcholine Receptor Binding and Its Relationship to Mild Cognitive and Depressive Symptoms in Parkinson Disease
Philipp M. Meyer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Interaction of Bupropion with Muscle-Type Nicotinic Acetylcholine Receptors in Different Conformational States
Hugo R. Arias et al.
BIOCHEMISTRY (2009)
α7 nicotinic acetylcholine receptor activation ameliorates scopolamine-induced behavioural changes in a modified continuous Y-maze task in mice
John R. Redrobe et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders
Ingrid Bacher et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder - A preliminary study
Tony P. George et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine
Justin W. Kenney et al.
MOLECULAR NEUROBIOLOGY (2008)
Nonsynaptic chemical transmission through nicotinic acetylcholine receptors
Balazs Lendvai et al.
PHYSIOLOGICAL REVIEWS (2008)
A buried lysine that titrates with a normal pKa:: Role of conformational flexibility at the protein-water interface as a determinant of pKavalues
Michael J. Harms et al.
PROTEIN SCIENCE (2008)
Serotoninergic dorsal raphe neurons possess functional postsynaptic nicotinic acetylcholine receptors
Luis Galindo-Charles et al.
SYNAPSE (2008)
3-[(aryl)(4-fluorobenzyloxy)methyl]piperidine derivatives: high-affinity ligands for the serotonin transporter
Susanna Nencetti et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Cholinergic axons modulate GABAergic signaling among hippocampal interneurons via postsynaptic α7 nicotinic receptors
Nicolas Wanaverbecq et al.
JOURNAL OF NEUROSCIENCE (2007)
Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells
M. Bliziotes et al.
BONE (2006)
Human tobacco smokers in early abstinence have higher levels of β2* nicotinic acetylcholine receptors than nonsmokers
Julie K. Staley et al.
JOURNAL OF NEUROSCIENCE (2006)
Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors
Hugo R. Arias et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine:: A 19-F MRS study
ME Henry et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Desensitization of nicotinic ACh receptors: shaping cholinergic signaling
R Giniatullin et al.
TRENDS IN NEUROSCIENCES (2005)
Refined structure of the nicotinic acetylcholine receptor at 4 Å resolution
N Unwin
JOURNAL OF MOLECULAR BIOLOGY (2005)
Co-morbidity of smoking in patients with psychiatric and substance use disorders
D Kalman et al.
AMERICAN JOURNAL ON ADDICTIONS (2005)
Coupling of human nicotinic acetylcholine receptors α7 to calcium channels in GH3 cells
D Feuerbach et al.
NEUROPHARMACOLOGY (2005)
Central monoamines and their role in major depression
AS Elhwuegi
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Trends in the development of new antidepressants. Is there a light at the end of the tunnel?
P Pacher et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Characterization of the human nicotinic acetylcholine receptor subunit alpha (α) 9 (CHRNA9) and alpha (α) 10 (CHRNAIO) in lymphocytes
HS Peng et al.
LIFE SCIENCES (2004)
Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors
J Garcia-Colunga et al.
PHARMACOGENOMICS JOURNAL (2004)
Antidepressants Noncompetitively Inhibit Nicotinic Acetylcholine Receptor Function
John D Fryer et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants
F Gumilar et al.
NEUROPHARMACOLOGY (2003)
Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram
P Popik et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus:: possible role of α7 receptors
SA Tucci et al.
NEUROPHARMACOLOGY (2003)
Effect of nicotine and nicotinic receptors on anxiety and depression
MR Picciotto et al.
NEUROREPORT (2002)
Nicotinic acetylcholine receptors as targets for antidepressants
RD Shytle et al.
MOLECULAR PSYCHIATRY (2002)
Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake
HE López-Valdés et al.
MOLECULAR PSYCHIATRY (2001)
Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy
RJ Steingard et al.
BIOLOGICAL PSYCHIATRY (2000)
Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy
NR Bolo et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Share Paper
